Home > Insider Trading > Filing (0001209191-19-014797)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406652	C Douglas Bryant	12544 High Bluff Drive, Suite 200 San Diego CA 92130	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-02-26	20,920	$15.28	322,006	No	4	M	Direct
Common Stock	Acquisiton	2019-02-26	10,523	$12.63	332,529	No	4	M	Direct
Common Stock	Disposition	2019-02-26	31,443	$65.72	301,086	No	4	S	Direct
Common Stock	Acquisiton	2019-02-27	22,154	$12.63	323,240	No	4	M	Direct
Common Stock	Disposition	2019-02-27	22,154	$65.98	301,086	No	4	S	Direct
Common Stock	Acquisiton	2019-02-28	22,153	$12.63	323,239	No	4	M	Direct
Common Stock	Disposition	2019-02-28	22,153	$65.62	301,442	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options	Disposition	2019-02-26	20,920	$0.00	20,920	$15.28
Common Stock	Non-Qualified Stock Options	Disposition	2019-02-26	10,523	$0.00	10,523	$12.63
Common Stock	Non-Qualified Stock Options	Disposition	2019-02-27	22,154	$0.00	22,154	$12.63
Common Stock	Non-Qualified Stock Options	Disposition	2019-02-28	22,153	$0.00	22,153	$12.63

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-01-18	No	4	M	Direct
75,395	2021-03-02	No	4	M	Direct
53,241	2021-03-02	No	4	M	Direct
31,088	2021-03-02	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $65.72 per share, with a range of $65.18 to $67.34. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $65.98 per share, with a range of $65.30 to $66.50. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $65.62 per share, with a range of $65.00 to $66.39. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The amount of securities beneficially owned prior to this transaction included an additional 356 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
27,729 shares vested on 01/18/2012; 13,865 shares vested on 01/18/2013; 13,864 shares vested on 01/18/2014.
42,959 shares vested on 03/02/2013; 21,479 shares vested on 03/02/2014; 21,480 shares vested on 03/02/2015.